Viw Magazine

The Times


.

Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy

HONG KONG SAR - Media OutReach Newswire - 19 May 2026 - Amplexd Therapeutics, Inc. ("Amplexd"), a U.S.-based clinical-stage biotechnology company focused on women's health and underserved therapeutic areas, today announced authorization from the Hong Kong Department of Health to initiate a Phase 2 clinical trial evaluating its novel EGCg-based investigational therapy for precancerous cervical lesions associated with high-risk human papillomavirus (hr-HPV).

Read more …

LifeStyle

Signs Your Relationship Needs More Than Just a Date Night

Date nights get a lot of credit. Book a babysitter, go somewhere nice, put the phones away and recon...

Ever Wondered Why Cosmetic Clinics Are So Careful About What They Say Online?

No prices, no product names, no glowing influencer reviews. If cosmetic clinic marketing has ever ...

Honouring Faith and Family: Understanding Traditional Funeral Rites in Australia

Australia's funerals are as varied as its people. On a single day in any capital city, you might fin...

Instant Tan vs Gradual Tan vs Developing Tan: Which One Suits Which Occasion

Walk into the self tan aisle in any Australian pharmacy and three product categories stare back at...

hacklink esim českoHerabetTrBetvpntaraftarium24Sahabetmarsbahisjojobetbetparkstreameastnon gamstopBetimselçuksportsgrandpashabet resmi girişgrandpashabet resmi girişbets10 xbetimStreamEastsohbet hattıdeneme bonusdeneme bonusuStreamEastholiganbetseo ajansıyurtdışı turseo danışmanlığıseo uzmanıgrandpashabet resmi girişstreameastseo hizmetijojobetjojobet giriş